STI Care Beyond Biomedical Models: Addressing Stigma, Gender, and Psychosocial Dimensions

India’s sexually transmitted infection (STI) control programme has, for decades, been built on primarily a biomedical scaffold of syndromic case management, laboratory confirmation, partner notification, and drug supply chains.[1] This scaffold focused on expanding ICTC and STI clinic networks, integration with the National AIDS Control Programme which has led to measurable declines in several infection indicators, most notably a fall in new HIV infections of 37% since 2010 and 86% since the epidemic’s peak in 1997.[2] Yet clinic-based prevalence figures and cascade-of-care statistics tell only part of the story. A growing body of community-based and qualitative research from India points to a persistent gap between what the biomedical model treats and what patients actually experience,[3] a gap defined by stigma, gendered vulnerability, and unaddressed psychosocial distress.

THE LIMITS OF A PURELY BIOMEDICAL LENS

The biomedical model treats an STI as a discrete, curable event and involves identifing the organism, prescribing the treatment regimen, confirming cure, notifying partners and closing the case. While this framework works well for the infection but it falls short of the holistic management for the person carrying it.

Engel’s foundational critique of biomedicine argued that a model confined to only biological variables leaves no room for the psychological and social dimensions of illness, and is therefore incomplete as a basis for complete clinical care.[4] Applied to STI services, it translates to the absence of focus on stigma that leads to delays in care-seeking by weeks or months, the marital conflict that follows a positive test, or the anticipated social prejudice that keeps patients from disclosing symptoms even to family physicians. When outcome measures stop at “treatment completed,” programmes can declare success while patients remain isolated, anxious, or trapped in relationships strained by suspicion and blame.

STIGMA AS A STRUCTURAL BARRIER, NOT A SIDE EFFECT

Stigma around STIs in India is not incidental to care-seeking behaviour; it is often the dominant determinant of it. A qualitative study of government healthcare providers found that social stigma and cultural barriers were among the principal obstacles to open communication and timely care for STI/RTI patients.[5] Associations between STIs and perceived sexual impropriety mean that a diagnosis can be read — by patients themselves and by those around them — as a moral failing rather than a medical event. This produces predictable consequences: self-treatment with over-the-counter medication, reliance on informal or unqualified providers, reluctance to attend government ICTC and STI clinics where confidentiality may feel uncertain, and non-disclosure to spouses or partners even when notification is medically indicated.

Stigma is also intersectional rather than singular: among men who have sex with men living with HIV in India, overlapping stigma related to sexual identity and HIV status has been shown to shape whether and how patients engage with antiretroviral care,[6] and a recent scoping review of health of LGBTQ+ in India similarly links compounded, identity-based stigma to poorer health-seeking behaviour and restricted access to services.[7] The current system is not designed to actively counter stigma through, for example, provider sensitisation, confidential service delivery, and community engagement and will thus continue to under-detect and under-treat, regardless of how well-stocked the pharmacy is.

GENDER: ASYMMETRIC RISK, ASYMMETRIC CONSEQUENCE

STI epidemiology cannot be completely understood without a gender lens. Because the exposure, diagnosis, and consequence are distributed unevenly between men and women. Facility-based data from an STI clinic in Uttarakhand illustrates how women often present with a mix of symptomatic and incidentally detected infection, underscoring how easily female cases are missed or delayed under a predominantly symptom-triggered model of care.[8] A study of married women attending a reproductive health clinic in Madhya Pradesh similarly found that treatment-seeking for RTI/STI symptoms remained low despite reasonable awareness, pointing to barriers that knowledge alone does not resolve accessibility and many important socio-cultural factors prevail like the limited autonomy over health-seeking and dependence on a spouse’s willingness to permit a clinic visit.[9] The consequences of a diagnosis are also asymmetric: women disproportionately bear the burden of infertility, pregnancy complications, and social sanction, including blame for infections that many times in fact have been introduced by a partner. The programmatic responses that treat men and women as similar biomedical entity moving through the same clinical cascade obscure these differences and risks designing sub-optimal services.

THE PSYCHOSOCIAL DIMENSION: UNDOCUMENTED, UNDERTREATED

Anxiety, depression, relationship breakdown, and diminished self-worth following an STI diagnosis are well documented, yet they rarely appear in programme monitoring indicators or in the outcome measures used by most evaluation studies. A large cross-sectional survey of STD clinic attendees in Shanghai found clinically significant anxiety and depressive symptoms in roughly one in ten to one in seven patients, with higher burden among women and those with poorer disease knowledge.[10] Related work among STI patients has shown that psychosocial problems like low self-esteem, loneliness, and feelings of entrapment compound with one another to sharply magnify the risk of depression, describing a syndemic effect rather than an isolated one.[11] This is a documentation gap with real consequences: a patient who is cured microbiologically but remains psychologically distressed, socially isolated, or at risk of relationship dissolution should not be labelled to have received complete care. Integrating brief psychosocial screening and referral pathways into STI/RTI services — without requiring specialist mental health infrastructure at every clinic — is a feasible, evidence-informed extension of existing syndromic management protocols.

None of this argues against the biomedical achievements of India’s STI/RTI programme; syndromic management and laboratory-supported diagnosis remain essential. The argument is for addition, not replacement. A biopsychosocial model of STI care would retain the clinical rigour while building in three additional elements: routine, non-judgmental stigma-reduction communication at every point of contact; gender-responsive service design that accounts for differential access, disclosure norms, and risk perception; and structured attention to existing or emergent psychosocial sequelae of diagnosis, with clear referral pathways where distress is identified. None of this need be built from scratch — a community-based intervention using self-help groups to deliver RTI/STI health education in Karnataka demonstrated that peer-led, socially embedded platforms can improve knowledge and health-seeking behaviour at low cost,[12] and similar models could be adapted specifically to carry stigma-reduction and psychosocial-literacy messaging. Provider training curricula, supervision checklists, and monitoring frameworks all offer further practical entry points for this shift — it does not require new infrastructure so much as a broadened definition of what “case management” includes.

CONCLUSION

STIs are transmitted between people, diagnosed within families, and experienced within social hierarchies of gender and morality. A programme that measures its success purely in cure rates and case-detection numbers will continue to miss the lived reality of the patients it serves. Community-based and qualitative research from across India — from urban ICTC attendees to rural and tribal populations — converges on the same message: stigma, gender, and psychosocial wellbeing are not peripheral concerns to STI care. They are central to whether patients seek care at all, complete treatment, disclose to partners, and recover in the fullest sense of the word.